CD34+ autologous human stem cells in treating refractory angina

Circulation Research

Volumn 109, Issue 4, 2011, Pages 351-352

  Perin, Emerson C ^a   Willerson, James T ^a  

^a TEXAS HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; PLACEBO;

ANGINA PECTORIS; AUTOLOGOUS BONE MARROW MONONUCLEAR CELL; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CD34+ AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); EDITORIAL; HEART VENTRICLE FUNCTION; HUMAN; HUMAN CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANGINA PECTORIS; ANIMALS; ANTIGENS, CD34; BIOLOGICAL MARKERS; CORONARY CIRCULATION; ENDOTHELIAL CELLS; EXERCISE TOLERANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICROCIRCULATION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PATIENT SELECTION; REGENERATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 80051769515     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.111.250696     Document Type: Editorial

References (17)

1. + cell therapy for refractory angina. Circ Res. 2011;109:428-436.
2. Beitnes JO, Hopp E, Lunde K, Solheim S, Arnesen H, Brinchmann JE, Forfang K, Aakhus S. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Heart. 2009;95:1983-1989.
3. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM. Intracoronary bone marrowderived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210-1221. (Pubitemid 44427445)
4. Strauer BE, Yousef M, Schannwell CM. The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study. Eur J Heart Fail. 2010;12:721-729.
5. Cardiac cell therapy: bench or bedside? Nat Clin Pract Cardiovasc Med. 2007;4:403.
6. Nadal-Ginard B, Fuster V. Myocardial cell therapy at the crossroads. Nat Clin Pract Cardiovasc Med. 2007;4:1. (Pubitemid 44971059)
7. Perin EC, Silva G, Gahremanpour A, Canales J, Zheng Y, Cabreira-Hansen MG, Mendelsohn F, Chronos N, Haley R, Willerson JT, Annex BH. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia. Catheter Cardiovasc Interv. Published online before print May 18, 2011. doi:10.1002/ccd.23066. Available at: http://onlinelibrary.wiley.com/doi/10.1002/ ccd.23066/abstract;jsessionid=63382F1FB5430ECDCF7667FBE56ADEBD.d02t01. Accessed July 5, 2011.
8. Perin EC, Sanchez PL, Ruiz RS, Perez-Cano R, Lasso J, Alonso-Farto JC, Fernandez-Pina L, Serruys PW, Duckers HJ, Katsrup J, Chameleau S, Zheng Y, Silva GV, Milstein AM, Martin MT, Willerson JT, Aviles FF. First in man transendocardial injection of autologous adipose-derived stem cells in patients with non revascularizable ischemic myocardium (PRECISE). Circulation. 2010;122:A17966. Abstract.
9. Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, Poh KK, Weinstein R, Kearney M, Chaudhry M, Burg A, Eaton L, Heyd L, Thorne T, Shturman L, Hoffmeister P, Story K, Zak V, Dowling D, Traverse JH, Olson RE, Flanagan J, Sodano D, Murayama T, Kawamoto A, Kusano KF, Wollins J, Welt F, Shah P, Soukas P, Asahara T, Henry TD. Intramyocardial transplantation of autologous CD34 + stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation. 2007;115:3165-3172. (Pubitemid 47018140)
10. Perin EC, Silva GV, Assad JA, Vela D, Buja LM, Sousa AL, Litovsky S, Lin J, Vaughn WK, Coulter S, Fernandes MR, Willerson JT. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol. 2008;44:486-495. (Pubitemid 351374698)
11. + cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res. 2010;106:1904-1911.
12. Zhang S, Shpall E, Willerson JT, Yeh ET. Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circ Res. 2007;100:693-702. (Pubitemid 46594884)
13. Zhang S, Wang D, Estrov Z, Raj S, Willerson JT, Yeh ET. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation. 2004;110:3803-3807. (Pubitemid 40023979)
14. + cells differentiate into cardiac myocytes via age-dependent paracrine mechanisms. Circ Res. 2007;100:e1-e11. (Pubitemid 46066765)
15. Dixon JA, Gorman RC, Stroud RE, Bouges S, Hirotsugu H, Gorman JH 3rd, Martens TP, Itescu S, Schuster MD, Plappert T, St John-Sutton MG, Spinale FG. Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation. 2009;120(suppl):S220-S229.
16. Silva GV, Fernandes MR, Cardoso CO, Sanz RR, Oliveira EM, Jimenez-Quevedo P, Lopez J, Angeli FS, Zheng Y, Willerson JT, Perin EC. A dosing study of bone marrow mononuclear cells for transendocardial injection in a pig model of chronic ischemic heart disease. Tex Heart Inst J. 2011;38:219-224.
17. + cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J. 2011;161:98-105.